Is the Injectable Cholesterol Medicine Effective?

The recently FDA approved medicine Praluent (alirocumab)‎ and Repatha (evolocumab) belong to PCSK9 inhibitors family. It’s the first injection treatment for lowering LDL cholesterol level and decrease risk in cardiovascular disease.

The injection treatment can be used alone or together with Statin. Based on research numbers, the combination of the injection treatment and Statin can reduce 75% of the LDL cholesterol. For people who have family history or who can’t lower down LDL cholesterol level with Statin alone, this is a super good news. 

There’re a small group of people who can’t tolerate the side effects of statins. Now this group has an alternative. 

The injection starts from 75 mg once every two weeks. If your body doesn’t respond  to it well, your doctor may increase the dosage to 150 mg once every two weeks. 


Related FAQs:

Very Low LDL Cholesterol Causes Cancer?

High Cholesterol Risks

Is High Blood Pressure Highly Correlated with Snoring?

* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.